HKPD
Cellyan Biotechnology Ltd.
NASDAQ · Healthcare · Medical - Pharmaceuticals · HK
$0.13
−8.86%Forward multiples
Based on analyst estimates
- P/E forward
- —
- P/E 2026E
- —
- P/E 2027E
- —
- P/E 2028E
- —
- P/S forward
- —
Trailing multiples
Trailing twelve months
- P/E TTM
- —
- PEG TTM
- —
- Price / book
- 0.65x
- Price / sales
- 0.18x
- Price / cash flow
- -33.93x
Enterprise value
- Enterprise value
- $7.2M
- EV / sales
- 0.21x
- EV / EBITDA
- -11.08x
- EV / EBIT
- -8.37x
- Market cap
- $6.2M
Trailing, forward and enterprise-value multiples for the requested listing · Data as of Mar 1, 2026